Vysum

We are delighted to announce that Vysum has been selected as a winner of the 2024 Innovation Catalyst Award, offered by the UNSW Tyree Foundation Institute of Health Engineering. Vysum is awarded $50,000 in tailored translational support to overcome key barriers in progressing our medical technology innovation. Thank you to the team, especially Ian Goon Sandy Wigley Scott Hebenton for your support so far, and we look forward to collaborating with the team and its extended network in the next 12 months. Congratulations to the other winners, who are also on a journey to deliver transformative advancements in healthcare. Lorace (Tianshu) Zhang | Li Hoo | Kiaran Lawson | Connie Zhang | Jeeng Hao Low #EyeCare #EyeHealth #MedTech #Innovation #HealthcareInnovation

Congratulations to Jane Chen for completing their internship with us! 🎉 Jane brought enthusiasm, creativity, and initiative to Vysum, from enhancing our website and LinkedIn content to supporting our founders with market research and business modeling. Her eye for detail as a talented photographer added a unique touch to our branding efforts! We’re so grateful for all your hard work, Jane, and we know you’ll bring the same passion and skill to whatever comes next. It’s been a pleasure having you on the team, and we’re excited to see where your next steps take you. 🌟 Wishing you all the best, Jane—keep shining bright! #congratulations #thankyou

🌟October is Blindness Awareness Month. Our Founder, Lorace (Tianshu) Zhang, reflects on a memorable conversation with a remarkable glaucoma patient, Lena. “Lena is one of the most beautiful and vibrant people I have ever met. In her mid-70s, she is bubbly, active, and stylish, with a passion for yoga and aqua acrobatics. She has managed glaucoma for 15 years, and her ophthalmologist is thrilled with her progress.” However, glaucoma and sight loss carry a profound weight that influences daily life and well-being, as Lena shares: “I’ve been reading memoirs from people who are blind. It’s tough to read, but I need to prepare myself for the possibility of going blind.” On that day, she pointed to her sweater and asked, “Would I be able to tell this is my favorite sweater just by touching the textile?” Lena’s insights made us more determined to improve the delivery and management of eye drops, the first line of treatment for glaucoma. We thank Lena and many, many more eye drop users who kindly shared their time and stories with us. We are always here to listen and support, and we take pride in contributing to better eye care for Australians. #BlindnessAwarenessMonth

Very excited to see TRAM Air founders highlighted in the The Enterprising Melbourne Review 2023 - Mahdi Miri Disfani Lorace (Tianshu) Zhang ⭐️ ⭐️ the teams are growing from milestone to milestone and it's exciting to celebrate their successes with a wider ecosystem. The Review is the University of Melbourne’s first annual publication showcasing commercialisation and entrepreneurship highlights, metrics and inspiring case studies of industry partnerships, social ventures and startups active in the University’s innovation ecosystem during 2023. Download the Enterprising Melbourne Review 2023 here: https://lnkd.in/gcisyYwJ Translating Research at Melbourne Porous Lane Vysum

💡 Did you know the Pharmaceutical Benefits Scheme (PBS) lists over 100 types of eye drops for conditions like glaucoma, dry eye, infections, and inflammation? At Vysum, we're committed to revolutionizing eye drop delivery and its management. Our daily mission is to explore the intricacies of eye drop formulations and bottle designs. From unique liquid properties to the varying shapes, sizes, and rigidities of bottles, the diversity is both fascinating and challenging! We’re passionate about simplifying this complexity to enhance patient experience. Stay tuned as we continue our journey toward better eye care solutions!💧👁️ #Eyecare #Innovation #MedTech #Pharmaceuticals #Vysum

As eye enthusiasts, we were thrilled to visit the Singapore National Eye Centre (SNEC), the designated national centre within the Singapore public sector healthcare network. Our Co-Founder Lorace (Tianshu) Zhang had the privilege of meeting Professor Aung Tin, CEO of SNEC, an internationally renowned clinician-scientist, and a senior glaucoma consultant. We had a great discussion on Singapore's innovation landscape, eye drop adherence, and SNEC’s initiatives to prevent blindness from glaucoma. Thank you, Professor Aung, for your encouraging words as we work to make an impact in the eye care industry. We're excited about the opportunities for early-stage companies in Singapore and look forward to visiting again in the near future! #MedTech #EyeHealth #HealthcareInnovation

What a fun and rewarding few days in Singapore! Our Co-Founder Lorace (Tianshu) Zhang enjoyed connecting with the local innovation ecosystem, including MedTech Actuator, Singapore Biodesign, A*StartCentral, and the Australian Trade and Investment Commission (Austrade). Thank you, Evon Liu from Medtech Actuator, for generously hosting us and sharing your insights into Singapore's ophthalmic innovation landscape, drawing on your experience as a clinician and innovation facilitator. It was wonderful to visit Singapore Biodesign to catch up with old friends Mark Chong and Masaomi Saeki, meet new friends Alexander Tonkin and Xiaoxi Wang, and learn from Anthony Chong about the innovation supported by A*StartCentral. A special thanks to A/Prof Desmond Y.R. Chong for your valuable connections and advice on technology commercialization in Singapore! We also had the opportunity to learn from the global ecosystem expert Diana Pang about the Singaporean commercialization landscape, as well as the challenges and opportunities for startups targeting Singapore as a beachhead. We're excited to explore future collaborations and opportunities within Singapore’s dynamic innovation landscape. Looking forward to continuing these meaningful conversations and driving impactful change together! #MedTech #EyeHealth #HealthcareInnovation

In just two weeks, our CEO Lorace (Tianshu) Zhang, will be heading to Singapore for a five-day visit to explore and connect with the local community. Did you know that around 3% of Singaporeans over the age of 50 are affected by glaucoma, and this percentage rises with age, reaching almost 10% for those aged 70 and above? Additionally, according to the Singapore National Eye Centre, approximately 34% of blindness cases in Singapore are due to glaucoma. These statistics highlight the pressing need for improved eye care options. One highlight of this trip will be the visit to MedTech Actuator Singapore, a leading accelerator program that supports health start-ups in scaling operations and commercialising innovations. At Vysum, we are dedicated to empowering patients and clinicians with advanced delivery and management tools for eye drop treatment. Our mission is to make a positive impact on the lives of those affected by glaucoma and other eye conditions. Stay tuned for more updates on Lorace's visit and our initiatives in Singapore. Together, let's create a brighter future for eye health! 🌍✨ #MedTech #EyeHealth #HealthcareInnovation

Again in 2024, Vysum is excited to be attending #DHF24 on May 7 & 8, 2024 at Melbourne’s MCEC! Join this transformative event with 6,000+ senior health execs shaping healthcare's future. Come and find our team at the Startup Village in #DHF24, and learn about how Vysum improves eye drop delivery and chronic condition management with digital and hardware technologies. #startup #medtech #digitalhealth #glaucoma

Curious about the impact TRAM Air has had on our past cohorts? Hear it straight from our alumni themselves:     "Being part of TRAM Air has been amazing. We enjoyed attending structured workshops, catching up frequently with advisors, working together with a friendly team, and presenting at the investor breakfast. Through TRAM Air, Vysum has become more investor-ready, and we have gained many invaluable connections."   - Lorace (Tianshu) Zhang, Founder and CEO of Vysum     “The TRAM Air program equipped me and the Porous Lane team with much needed knowledge and insight on how to attract investment and become investment ready. The workshops and tailored mentoring were highly valuable. I believe that over the course of program I became more of an entrepreneur and less of an academic.   TRAM Air brought me into the start-up ecosystem. It wasn’t just a training; it was an experience that I lived and one that changed me”   - Mahdi Miri Disfani, Founder of Porous Lane     "TRAM Air has jumpstarted our fundraising journey by providing the essential insights necessary for investor readiness, as well as making connections to investors within our industry."  - Dr Bec McCormick, CEO of Anura Medical    We are looking for more teams like Vysum, Porous Lane and Anura Medical with the drive to turn their vision into reality!     TRAM Air supports the best of the University of Melbourne research community to build and scale impactful, investable ventures and applications are now open.   Book a call with Masha, our TRAM Air Program Manager, to learn more and start the application process -- https://lnkd.in/gwuAqqCD  #TRAMAir #unimelb #researchimpact